Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Winston Pharmaceuticals, Inc. (“Winston”), a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of...
Winston Pharmaceuticals, Inc. (“Winston”), a pharmaceutical company focused on developing and commercializing novel pain management therapies today announced that senior...
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. (“Winston”) (OTC PINK: WPHM), a pharmaceutical company focused on developing and...
Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. (“Winston”) (OTC PINK: WPHM), a pharmaceutical company focused on developing and...
Winston Laboratories, Inc. (“Winston Labs”), a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. (OTC BB: WPHM) today announced positive top-line results from Study...
Winston Pharmaceuticals, Inc. (OTC BB: WPHM) today announced that senior management will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday...
Winston Laboratories, Inc. (“Winston Labs”), a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. (OTC BB: WPHM) today announced that it has received a Notice of...
Winston Pharmaceuticals, Inc. (OTC BB: WPHM) (the “Company”) today announced that Joel E. Bernstein, M.D., the founder of Winston Laboratories, Inc., the Company’s wholly-owned...
Winston Pharmaceuticals, Inc. (OTC BB: WPHM) (the “Company”) today announced that Joel E. Bernstein, M.D., the founder of Winston Laboratories, Inc., the Company’s wholly-owned...
Winston Pharmaceuticals, Inc. (OTC BB: WPHM) today announced that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its lead compound...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.3 | 1.0E-6 | 553 | 0.06352051 | CS |
| 260 | -0.009999 | -99.99 | 0.01 | 0.3 | 1.0E-6 | 5537 | 0.04653558 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| RDARRaadr Inc (PK) | US$ 0,0009 (0,00%) | 251,75M |
| ASTAAstra Veda Corporation (PK) | US$ 0,0002 (0,00%) | 92,65M |
| HCMCHealthier Choices Management Corporation (PK) | US$ 0,000001 (-99,00%) | 71,06M |
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,0029 (5,45%) | 56,69M |
| ONCIOn4 Communications Inc (PK) | US$ 0,0001 (0,00%) | 41,77M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
